Extended Use of Pharmaceutical GMP Facilities for Neutriceuticals Production

Published: 2004-12-13 07:00:00

Updated: 2004-12-13 07:00:00

The Ministry of Health and Welfare (MOHW) announced its allowance for the pharmaceutical companies to use their existing GMP-approved facilities to manufacture neutraceutical products as well.

Reflecting the MOHW’s efforts to foster and support the neutraceutical industry, the existing regulations are updated with special provisions in the area of facility standard requirements. In addition...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.